Hardy Diagnostics  

1430 W McCoy Lane
Santa Maria,  CA  93455-1005

United States
https://www.hardydiagnostics.com

• Booth: 451

Hardy Diagnostics manufactures over 3,500 different products used in the microbiology laboratory. The company is licensed by the FDA as an in vitro Medical Device Manufacturer and ISO 13485 Certified. There are two main manufacturing facilities: Santa Maria and Springboro, Ohio.

 Press Releases

• Hardy Diagnostics announces exclusive partnership for the US and Canada wit (May 05, 2025)
  Hardy Diagnostics entered into an exclusive partnership with the Swedish-based company Gradientech to distribute its FDA-classified breakthrough device, the QuickMIC®. The QuickMIC® results contribute to timely and effective management of sepsis patients, helping clinicians make faster antibiotic treatment decisions. Sepsis is a serious condition and a leading cause of death in hospitals. Each year, according to the Centers for Disease Control and Prevention, at least 1.7 million adults in the U.S. develop sepsis, and at least 250,000 die as a result. Sepsis is also the main reason why people are readmitted to the hospital. The National Institute for Health and Care Excellence urges hospital staff to treat people with life-threatening sepsis within one hour of diagnosis. In clinical practice, this is often referred to as the ‘golden hour.’ “We are confident that the QuickMIC® system will soon become the standard in the hospital laboratory and will be ultimately responsible for saving many lives,” says Jay Hardy, President and Founder of Hardy Diagnostics. 
  
  The QuickMIC® system is currently undergoing 510(k) clinical studies at two well-renowned hospitals in the United States. The QuickMIC® system is already available and in use at many hospitals in Europe. “As the exclusive distributor of QuickMIC in the US and Canada, Hardy Diagnostics will leverage its extensive network and knowledge of the clinical microbiology landscape to bring this innovative AST system to healthcare providers across North America. I believe few others can match Hardy Diagnostics' expertise in the US clinical microbiology market. Our two companies also share a common vision and place great value on our teams, ensuring a good partnership,” says Sara Thorslund, CEO of Gradientech.
   

 Products